ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Software Design Controls Engineer at Neuralink - ApplyBlast

Software Design Controls Engineer

Neuralink

2 months ago

3.5 on Glassdoor

Austin, Texas, United States

Onsite

Full Time

Medior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Software Design Controls Engineer at Neuralink will lead software design control strategy, processes, and documentation for implantable electronics, surgical robotics, and related systems, ensuring compliance with IEC 62304, ISO 14971, and ISO 13485. The role involves collaborating with software, firmware, quality, and regulatory teams to assess design changes, manage risk, and maintain the Design History File throughout the software lifecycle.

Responsibilities

Own end-to-end software design control strategy and execution
Assess design change impacts and maintain Design History File compliance
Debug software quality gaps using traceability matrices and root‑cause analysis

Skills

Qualifications

Bachelor's degree in Computer Science, Software Engineering, Biomedical Engineering or related technical discipline

About Neuralink

neuralink.com

Headquarters

Fremont, California, United States

Company Size

201-500 employees

Founded

2016

View Profile

Neuralink develops invasive brain–computer interface technologies aimed at restoring neurological function and expanding human capabilities. The company builds implantable neural devices with ultra‑thin electrode threads, a robotic surgical system for automated implantation, and wireless electronics to read and stimulate brain activity, targeting conditions like paralysis and ALS. Neuralink is pursuing clinical trials and works across neuroscience, engineering, and medicine to translate its BCI platform into safe, scalable therapies and future applications for augmented cognition.